Mazindol
Back to searchMolecule Structure
Scientific Name
Mazindol
Description of the Drug
Mazindol is a sympathomimetic used to treat obesity in combination with lifestyle modifications.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00579
http://www.drugbank.ca/drugs/DB00579
Brand Name(s)
Mazanor, Sanorex, Teronac
Company Owner(s)
Wyeth Ayerst Laboratories, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Monoamine transporter | PROTEIN FAMILY | INHIBITOR | CHEMBL2363064 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL27849 | |
| PharmGKB | PA450326 | |
| Human Metabolome Database | HMDB0014718 | |
| WDI | MAZINDOL | |
| DrugBank | DB00579 | |
| PubChem: Thomson Pharma | 14897762 | |
| PubChem | 4020 | |
| LINCS | LSM-45791 | |
| Nikkaji | J11.418I | |
| EPA CompTox Dashboard | DTXSID1023237 | |
| DrugCentral | 1640 | |
| Guide to Pharmacology | 4797 | 4591 |
| GSRS | b1b22ad8-69df-419c-abce-0e4577b7d1c5 | |
| rxnorm | MAZINDOL | |
| PubChem: Drugs of the Future | 99431540 | |
| ChEBI | 6702 |
